Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Salivary duct carcinomas can be classified into luminal androgen receptor-positive, HER2 and basal-like phenotypes.

Histopathology - 1 Oct 2012

Di Palma Silvana, Simpson Roderick H W, Marchiò Caterina, Skálová Alena, Ungari Marco, Sandison Ann, Whitaker Stephen, Parry Suzanne, Reis-Filho Jorge S

Abstract excerpt

AIMS: The aim of this study was to devise a molecular classification for salivary duct carcinomas (SDCs) based on the similarities between SDCs and breast carcinomas and on characteristics of the microarray-based gene expression profiling-defined molecular subtypes of breast cancer. METHODS AND RESULTS: Forty-two pure salivary duct carcinomas, 35 of which contained an in-situ component as defined by histological...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Biomarkers, Tumor

Share to Carcinoma

Share to EGFR gene

Share to Immunohistochemistry

Share to In Situ Hybridization

Share to Phenotype

Source

Identifiers

PMID: 22882517
DOI: 10.1111/j.1365-2559.2012.04252.x

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Salivary duct carcinomas can be classified into luminal androgen receptor-positive, HER2 and basal-like phenotypes.PMID 22882517Read ↗

[Salivary duct carcinomas comprise phenotypically and genotypically diverse high grade neoplasms].Semantic proximity Read ↗

Salivary duct carcinoma: Clinicopathologic features, morphologic spectrum, and somatic mutations.Semantic proximity Read ↗

Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients.Semantic proximity Read ↗

Novel therapeutic targets in salivary duct carcinoma uncovered by comprehensive molecular profilingSemantic proximity Read ↗

Comprehensive Molecular Characterization of Salivary Duct Carcinoma Reveals Actionable Targets and Similarity to Apocrine Breast Cancer.Semantic proximity Read ↗

Salivary duct carcinoma: An aggressive salivary gland malignancy with opportunities for targeted therapy.Semantic proximity Read ↗

Intraductal Carcinomas of the Salivary Gland.Semantic proximity Read ↗

Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer.Semantic proximity Read ↗

Identification of novel prognostic and predictive biomarkers in salivary duct carcinoma via comprehensive molecular profilingSemantic proximity Read ↗

The molecular landscape and microenvironment of salivary duct carcinoma reveal new therapeutic opportunitiesSemantic proximity Read ↗

Molecular patterns in salivary duct carcinoma identify prognostic subgroupsSemantic proximity Read ↗

Parotid Salivary Duct Carcinoma With a Prominent Squamous Component: Immunohistochemical Profile, Diagnostic Pitfalls, and Therapeutic Implications.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.